Korean J Dermatol.
2001 Nov;39(11):1313-1315.
A Case of Recalcitrant Psoriasis Improved with Tacrolimus (FK 506)
- Affiliations
-
- 1Department of Dermatology, College of Medicine, Dankook University Cheonan, Korea. kyccc@anseo.dankook.ac.kr
Abstract
- Tacrolimus(FK 506) is a powerful immunosuppressant. Recently, topical and systemic tacrolimus was known to have therapeutic effects in various dermatologic diseases such as atopic dermatitis, psoriasis, pyodema gangrenosum, and Beh et's disease. A 48-year-old woman presented with psoriasis of 40 years duration, which was recalcitrant to any therapies including topical steroids and calcipotriol, UVB, PUVA, acitretin, cyclosporine, and methotrexate. Therefore, systemic tacrolimus treatment, at a dose of 2 to 6 mg per day, was initiated, and complete resolution of the lesions was observed after 2 months. We report a case of recalcitrant psoriasis improved with tacrolimus.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Effect of FK 506 on the cornea: use of topical FK 506 in corneal transplantation in a guinea pig-rat model
- The Effects of Cyclosporin A and FK-506 on the Cytokine Production of Lymphocytes in Atopic Dermatitis
- Limb Allotransplantation In Rat Immunosuppressed with FK-506
- Two Cases of Atopic Dermatitis Treated with Thymopentin
- Nerve regeneration effect of FK-506 using local reserve flap
